FGF 23 and risk of all-cause mortality and cardiovascular events: a meta-analysis of prospective cohort studies

Int J Cardiol. 2014 Dec 15;177(2):575-7. doi: 10.1016/j.ijcard.2014.08.125. Epub 2014 Aug 27.

Authors

Yunjun Xiao¹, Xianru Luo², Wei Huang², Jinzhou Zhang², Chaoqiong Peng²

Affiliations

¹ Department of Nutrition and Food Hygiene, Shenzhen Center for Disease Control and Prevention, Shenzhen, China. Electronic address: xiaoyunjun2002@yahoo.com.cn.
² Department of Nutrition and Food Hygiene, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.

PMID: 25194866
DOI: 10.1016/j.ijcard.2014.08.125

No abstract available

Keywords: Cardiovascular disease; Cohort studies; Fibroblast growth factor 23; Meta-analysis.

Publication types

Letter
Comment

MeSH terms

Cardiovascular Diseases / blood*
Cardiovascular Diseases / mortality*
Fibroblast Growth Factor-23
Fibroblast Growth Factors / blood*
Humans

Substances

FGF23 protein, human
Fibroblast Growth Factors
Fibroblast Growth Factor-23